{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:45:22Z","timestamp":1784069122834,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["2\/381\/44"],"award-info":[{"award-number":["2\/381\/44"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijbiomac.2023.128812","type":"journal-article","created":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T17:41:38Z","timestamp":1702834898000},"page":"128812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"P1","title":["Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2"],"prefix":"10.1016","volume":"258","author":[{"given":"Muhammad","family":"Waqas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobia Ahsan","family":"Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najeeb Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afnan","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif Bin","family":"Muhsinah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"03","key":"10.1016\/j.ijbiomac.2023.128812_bb0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3855\/jidc.12671","article-title":"The novel zoonotic COVID-19 pandemic: an expected global health concern","volume":"14","author":"Contini","year":"2020","journal-title":"J. Infect. Dev. Ctries."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128812_bb0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41423-020-0407-x","article-title":"COVID-19: a new challenge for human beings","volume":"17","author":"Yang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0015","series-title":"WHO COVID-19 Dashboard, Geneva","author":"W.H. Organization","year":"2020"},{"issue":"10238","key":"10.1016\/j.ijbiomac.2023.128812_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31185-5","article-title":"Electron microscopy of SARS-CoV-2: a challenging task\u2013authors\u2019 reply","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128812_bb0025","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41596-021-00491-8","article-title":"Engineering SARS-CoV-2 using a reverse genetic system","volume":"16","author":"Xie","year":"2021","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0030","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1038\/s41467-021-23779-5","article-title":"A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses","volume":"12","author":"Amarilla","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.128812_bb0035","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.5858\/arpa.2020-0820-SA","article-title":"A comparison of the clinical, viral, pathologic, and immunologic features of severe acute respiratory syndrome (SARS), middle east respiratory syndrome (MERS), and coronavirus 2019 (COVID-19) diseases","volume":"145","author":"Barth","year":"2021","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.128812_bb0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/v11121119","article-title":"A comparative analysis of factors influencing two outbreaks of Middle Eastern respiratory syndrome (MERS) in Saudi Arabia and South Korea","volume":"11","author":"Willman","year":"2019","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.128812_bb0045","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.128812_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14004","article-title":"Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants","volume":"53","author":"Ali","year":"2023","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128812_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.11.024","article-title":"Structural insights into SARS-CoV-2 proteins","volume":"433","author":"Arya","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijbiomac.2021.07.184","article-title":"Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease","volume":"188","author":"Xu","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128812_bb0065","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acsptsci.0c00093","article-title":"Can papain-like protease inhibitors halt SARS-CoV-2 replication?","volume":"3","author":"Maiti","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128812_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13044","article-title":"Interactions between SARS coronavirus 2 papain-like protease and immune system: a potential drug target for the treatment of COVID-19","volume":"94","author":"Mahmoudvand","year":"2021","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41392-021-00733-x","article-title":"Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.128812_bb0080","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s13238-022-00909-3","article-title":"Targeting papain-like protease for broad-spectrum coronavirus inhibition","volume":"13","author":"Yuan","year":"2022","journal-title":"Protein Cell"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128812_bb0085","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acscentsci.1c00519","article-title":"Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and a FlipGFP-based reporter assay","volume":"7","author":"Ma","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128812_bb0090","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/acs.jmedchem.1c01307","article-title":"Design of SARS-CoV-2 PLpro inhibitors for COVID-19 antiviral therapy leveraging binding cooperativity","volume":"65","author":"Shen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2021.112984","article-title":"Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease","volume":"193","author":"Li","year":"2022","journal-title":"Phytochemistry"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128812_bb0100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jiph.2023.02.009","article-title":"Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation","volume":"16","author":"Aziz","year":"2023","journal-title":"J. Infect. Public Health"},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.128812_bb0105","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/ph14090896","article-title":"In silico prediction of novel inhibitors of SARS-CoV-2 main protease through structure-based virtual screening and molecular dynamic simulation","volume":"14","author":"Halim","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bioorg.2018.04.020","article-title":"New \u03b1-glucosidase inhibitors from the resins of Boswellia species with structure\u2013glucosidase activity and molecular docking studies","volume":"79","author":"Rehman","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128812_bb0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/biom10050751","article-title":"Triterpenic acids as non-competitive \u03b1-glucosidase inhibitors from Boswellia elongata with structure-activity relationship: in vitro and in silico studies","volume":"10","author":"Ur Rehman","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0120","article-title":"Boswellic acids with acetylcholinesterase inhibitory properties from frankincense","volume":"3","author":"Ota","year":"2008","journal-title":"Nat. Prod. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128812_bb0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/14786419.2019.1593165","article-title":"New derivatives of 11-keto-\u03b2-boswellic acid (KBA) induce apoptosis in breast and prostate cancers cells","volume":"35","author":"Bini Araba","year":"2021","journal-title":"Nat. Prod. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128812_bb0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12017-022-08707-0","article-title":"The biological activity of 3-O-acetyl-11-keto-\u03b2-boswellic acid in nervous system diseases","volume":"24","author":"Gong","year":"2022","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0135","first-page":"1","article-title":"3-O-acetyl-11-keto-\u03b2-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2\/M phase","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128812_bb0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.apsb.2019.12.012","article-title":"3-O-Acetyl-11-keto-\u03b2-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","article-title":"Crystal structure of SARS-CoV-2 papain-like protease","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"18","key":"10.1016\/j.ijbiomac.2023.128812_bb0150","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106275","article-title":"Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2","volume":"39","author":"Klemm","year":"2020","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128812_bb0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00836-9","article-title":"High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors","volume":"12","author":"Zhao","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0160","series-title":"Molecular Operating Environment (MOE), Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite 910, Montreal, QC, Canada","author":"C.C.G. ULC","year":"2022"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128812_bb0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00124456","article-title":"MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry","volume":"9","author":"Gerber","year":"1995","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128812_bb0170","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0175","volume":"2021","author":"Hma","year":"2021","journal-title":"Amber"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0180","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theory Comput."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128812_bb0185","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acs.jcim.0c01390","article-title":"Parameterization of monovalent ions for the OPC3, OPC, TIP3P-FB, and TIP4P-FB water models","volume":"61","author":"Sengupta","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0190","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/ct050212s","article-title":"A fast QM\/MM (quantum mechanical\/molecular mechanical) approach to calculate nuclear magnetic resonance chemical shifts for macromolecules","volume":"2","author":"Wang","year":"2006","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.128812_bb0195","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald","volume":"9","author":"Salomon-Ferrer","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0200","series-title":"Numerical Recipes: The Art of Scientific Computing","author":"Ziegel","year":"1987"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.128812_bb0205","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1021\/ct800573m","article-title":"Bad seeds sprout perilous dynamics: stochastic thermostat induced trajectory synchronization in biomolecules","volume":"5","author":"Sindhikara","year":"2009","journal-title":"J. Chem. Theory Comput."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128812_bb0210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","article-title":"A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations","volume":"22","author":"Kr\u00e4utler","year":"2001","journal-title":"J. Comput. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128812_bb0215","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.128812_bb0220","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1103\/PhysRevLett.80.2733","article-title":"Vibrational dynamics of folded proteins: significance of slow and fast motions in relation to function and stability","volume":"80","author":"Bahar","year":"1998","journal-title":"Phys. Rev. Lett."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128812_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178333","article-title":"Molecular dynamics analysis of the aggregation propensity of polyglutamine segments","volume":"12","author":"Wen","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128812_bb0230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discovery"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128812_bb0235","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/prot.20033","article-title":"Exploring protein native states and large-scale conformational changes with a modified generalized born model","volume":"55","author":"Onufriev","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0240","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ijbiomac.2022.09.204","article-title":"Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases","volume":"222","author":"Chaves","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0245","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41598-022-06104-y","article-title":"Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro","volume":"12","author":"Lewis","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0250","series-title":"In Vitro Toxicity Testing Protocols","first-page":"137","article-title":"MTT assays","author":"Supino","year":"1995"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.128812_bb0255","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2018.01.044","article-title":"Computational prediction of drug solubility in water-based systems: qualitative and quantitative approaches used in the current drug discovery and development setting","volume":"540","author":"Bergstr\u00f6m","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.128812_bb0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0265","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drudis.2019.10.014","article-title":"A drug-likeness toolbox facilitates ADMET study in drug discovery","volume":"25","author":"Jia","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128812_bb0275","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/ci960402j","article-title":"GraphPad prism, data analysis, and scientific graphing","volume":"37","author":"Swift","year":"1997","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"suppl_1","key":"10.1016\/j.ijbiomac.2023.128812_bb0280","doi-asserted-by":"crossref","first-page":"D354","DOI":"10.1093\/nar\/gkj102","article-title":"From genomics to chemical genomics: new developments in KEGG","volume":"34","author":"Kanehisa","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"5460","key":"10.1016\/j.ijbiomac.2023.128812_bb0285","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.287.5460.1960","article-title":"Drug discovery: a historical perspective","volume":"287","author":"Drews","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17460441.2018.1403419","article-title":"Molecular dynamics simulations and novel drug discovery","volume":"13","author":"Liu","year":"2018","journal-title":"Expert Opin. Drug Discovery"},{"issue":"16","key":"10.1016\/j.ijbiomac.2023.128812_bb0295","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1080\/14786419.2017.1356838","article-title":"Natural products for human health: an historical overview of the drug discovery approaches","volume":"32","author":"Bernardini","year":"2018","journal-title":"Nat. Prod. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128812_bb0300","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.18520\/cs\/v118\/i7\/1087-1092","article-title":"Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease","volume":"118","author":"Sampangi-Ramaiah","year":"2020","journal-title":"Curr. Sci."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0305","first-page":"1","article-title":"Pharmacotherapeutic potential of natural products to target the SARS-CoV-2 PLpro using molecular screening and simulation approaches","author":"Sayaf","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"2-s","key":"10.1016\/j.ijbiomac.2023.128812_bb0310","doi-asserted-by":"crossref","first-page":"366","DOI":"10.22270\/jddt.v9i2-s.2710","article-title":"In vitro ADME studies of TUG-891, a GPR-120 inhibitor using SWISS ADME predictor","volume":"9","author":"Mishra","year":"2019","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0315","series-title":"The ABCD of Clinical Pharmacokinetics","first-page":"5","author":"Doogue","year":"2013"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128812_bb0320","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijbiomac.2023.128812_bb0325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejps.2016.10.034","article-title":"BBB penetration-targeting physicochemical lead selection: ecdysteroids as chemo-sensitizers against CNS tumors","volume":"96","author":"M\u00fcller","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2023.128812_bb0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023057112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023057112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T10:04:32Z","timestamp":1765793072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023057112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":66,"alternative-id":["S0141813023057112"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128812","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128812"}}